The sirtuin family in health and disease
2022 · Signal Transduction and Targeted Therapy · 724 citations
https://doi.org/10.1038/s41392-022-01257-8
G
Gang Zheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
314
Papers
7.8K
Citations
45
h-index
145
i10-index
Gang Zheng is an academic researcher from University Health Network. The author has contributed to research in topics: Gestational Trophoblastic Disease Studies & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 45, co-authored 267 publications.
ORCID: 0000-0003-0276-9430Papers by this author
worksSmall molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration
2018 · Experimental & Molecular Medicine · 93 citations
https://doi.org/10.1038/s12276-018-0173-3
TFEB, a potential therapeutic target for osteoarthritis via autophagy regulation
2018 · Cell Death and Disease · 88 citations
https://doi.org/10.1038/s41419-018-0909-y
Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling
2022 · Journal of Nanobiotechnology · 59 citations
https://doi.org/10.1186/s12951-022-01400-1
Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP‐9 expression but not direct TJ proteins expression regulation
2017 · Journal of Cellular and Molecular Medicine · 42 citations
https://doi.org/10.1111/jcmm.13235
MiR-378a-3p/ SLC7A11 regulate ferroptosis in nerve injury induced by lead exposure
2022 · Ecotoxicology and Environmental Safety · 42 citations
https://doi.org/10.1016/j.ecoenv.2022.113639
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat